Business Description
ZYUS Life Sciences Corp
NAICS : 325412
SIC : 3741
ISIN : CA9899601095
Compare
Compare
Traded in other countries / regions
ZYUS.CanadaZLSCF.USA IPO Date
2023-06-19Description
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.84 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | -0.79 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -1.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.01 | |||||
| 9-Day RSI | 58.3 | |||||
| 14-Day RSI | 58.26 | |||||
| 6-1 Month Momentum % | 25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.13 | |||||
| Quick Ratio | 0.85 | |||||
| Cash Ratio | 0.66 | |||||
| Days Inventory | 5949.43 | |||||
| Days Sales Outstanding | 382.47 | |||||
| Days Payable | 12378.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.71 | |||||
| Operating Margin % | -4012.46 | |||||
| Net Margin % | -8158.66 | |||||
| FCF Margin % | -5291.49 | |||||
| ROE % | -104.72 | |||||
| ROA % | -38.14 | |||||
| ROIC % | -21.4 | |||||
| ROC (Joel Greenblatt) % | -105.08 | |||||
| ROCE % | -30.58 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 222 | |||||
| PB Ratio | 1.66 | |||||
| Price-to-Tangible-Book | 13.88 | |||||
| EV-to-EBIT | -4.7 | |||||
| EV-to-EBITDA | -5.75 | |||||
| EV-to-Revenue | 240.98 | |||||
| EV-to-Forward-Revenue | 185.24 | |||||
| EV-to-FCF | -4.55 | |||||
| Earnings Yield (Greenblatt) % | -21.28 | |||||
| FCF Yield % | -22.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ZYUS Life Sciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.329 | ||
| EPS (TTM) (C$) | -0.493 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 58.26 | ||
| 14-Day ATR (C$) | 0.043828 | ||
| 20-Day SMA (C$) | 1.04 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (C$) | 0.71 - 2.14 | ||
| Shares Outstanding (Mil) | 69.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ZYUS Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ZYUS Life Sciences Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
ZYUS Life Sciences Corp Frequently Asked Questions
What is ZYUS Life Sciences Corp(TSXV:ZYUS)'s stock price today?
The current price of TSXV:ZYUS is C$1.11. The 52 week high of TSXV:ZYUS is C$2.14 and 52 week low is C$0.71.
When is next earnings date of ZYUS Life Sciences Corp(TSXV:ZYUS)?
The next earnings date of ZYUS Life Sciences Corp(TSXV:ZYUS) is .
Does ZYUS Life Sciences Corp(TSXV:ZYUS) pay dividends? If so, how much?
ZYUS Life Sciences Corp(TSXV:ZYUS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers